Research & Development

在线精品视频不一样的视频网站不一样的任你操保险认购热情高 浦发银行完成300亿元永续债簿记定价


  焦渴難耐的歇古不由自主的將這些血水吞了下去……   他只看見了很多熟悉的面孔……在线精品视频   偷襲的軍令是霍去病以將軍的名義下達的,雲瑯不能反駁。不一样的视频网站   好多羌人從自家走出來,茫然的站在街道上,他們已經不知道該何去何從。   只是當管仲將青樓業與賭博業用官方的名義大肆開辦之後,強盛的齊國從此就再也無力北顧。不一样的任你操   正在低頭干活的婦人抬頭看了歇古一眼道︰“我不跟你說話。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo